POST Online Media Lite Edition


BioAmber appoints Richard P. Eno as CEO

Staff Writer |
Minneapolis, Mn., USA - September 15, 2017, Minneapolis, Mn., USA - BioAmber, an industrial biotechnology company, announced the appointment of Richard P. Eno as its new chief executive officer, and new member of the board.

Article continues below

Mr. Eno has over 30 years of related management experience in the energy, chemicals, biotechnology and materials industries, including over five years as President, CEO and Board member of a publicly traded industrial biotechnology company.

Mr. Eno has began his career in Chevron's chemical operations with roles of increasing responsibility in engineering, manufacturing and construction operations.

He then entered management consulting where he specialized in addressing critical strategic and operational issues facing company leadership in the chemical and energy industries.

In 2008, Mr. Eno has took up leadership of Metabolix, an industrial biotechnology company commercializing a range of unique bio-based, biodegradable polymers.

Most recently, he has been a senior partner at a global management consultancy, Roland Berger, focused on the chemicals industry.


What to read next

BioAmber appoints Raymond J. Land as interim CFO
BioAmber strengthens board of directors
Tekmira appoints Richard Henriques to board